Morphological imaging and CT histogram analysis to differentiate pancreatic neuroendocrine tumor grade 3 from neuroendocrine carcinoma von Azoulay, A., Cros, J., Vullierme, M.-P., de Mestier, L., Couvelard, A., Hentic, O., Ruszniewski, P., Sauvanet, A., Vilgrain, V., Ronot, M.

Volltext

FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide–platinum combination in patients with neuroendocrine carcinomas grade 3 von Hentic, O, Hammel, P, Couvelard, A, Rebours, V, Zappa, M, Palazzo, M, Maire, F, Goujon, G, Gillet, A, Lévy, P, Ruszniewski, P

Volltext

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort von Walter, T, Tougeron, D, Baudin, E, Le Malicot, K, Lecomte, T, Malka, D, Hentic, O, Manfredi, S, Bonnet, I, Guimbaud, R, Coriat, R, Lepère, C, Desauw, C, Thirot-Bidault, A, Dahan, L, Roquin, G, Aparicio, T, Legoux, J.-L, Lombard-Bohas, C, Scoazec, J.-Y, Lepage, C, Cadiot, G

Volltext

Updated Morphological and Immunohistochemical Profile of Neuroendocrine Tumors Developing in Ovarian Teratomas: A Large Series of a Rare and Heterogeneous Disease von Leclerc, J, Tihy, M, Genestie, C, Chen, R, Hentic, O, Koskas, M, Gouy, S, Scoazec, J Y, Couvelard, A, Bucau, Margot

Volltext

Role of FOXM1 in aggressive pancreatic / pulmonary neuroendocrine neoplasms and anti-tumor effect of the FOXM1 inhibitor Thiostrepton von De Rycke, O., Raffenne, J., Lacombe, C., Hentic, O., Gounant, V., Sauvanet, A., Zalcman, G., Paradis, V., Ruszniewski, P., Couvelard, A., De Mestier, L., Cros, J.

Volltext

Efficacy of alkylating agent rechallenge after therapeutic pause in metastatic pancreatic neuroendocrine tumors (PanNET) von De Rycke, O., Walter, T., Perrier, M., Hentic, O., Cadiot, G., Lombard Bohas, C., Ruszniewski, P., Cros, J., De Mestier, L.

Volltext

Can the efficacy of etoposide-platinum chemotherapy be predicted by p53/Rb status in grade 3 Neuroendocrine Neoplasms (G3 NEN)? von Lacombe, C., De Rycke, O., Chen, R., Colnot, N., Hentic, O., Cazes, A., Zalcman, G., Ruszniewski, P., Couvelard, A., Cros, J., De Mestier, L.

Volltext

Preoperative imaging and pathologic classification for pancreatic neuroendocrine tumors von Deguelte, S, de Mestier, L, Hentic, O, Cros, J, Lebtahi, R, Hammel, P, Kianmanesh, R

Volltext

Sporadic pancreatic neuroendocrine tumor: Surgery of the primary tumor von Deguelte, S, de Mestier, L, Hentic, O, Cros, J, Lebtahi, R, Hammel, P, Kianmanesh, R

Volltext

Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours von MARRACHE, F, VULLIERME, M. P, RAVAUD, P, ROUGIER, P, RUSZNIEWSKI, P, ROY, C, EL ASSOUED, Y, COUVELARD, A, O'TOOLE, D, MITRY, E, HENTIC, O, HAMMEL, P, LEVY, P

Volltext

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors von Caplin, Martyn E, Pavel, Marianne, Ćwikła, Jarosław B, Phan, Alexandria T, Raderer, Markus, Sedláčková, Eva, Cadiot, Guillaume, Wolin, Edward M, Capdevila, Jaume, Wall, Lucy, Rindi, Guido, Langley, Alison, Martinez, Séverine, Blumberg, Joëlle, Ruszniewski, Philippe

Volltext

568P FOLFOX-bevacizumab chemotherapy in patients with progressive metastatic neuroendocrine tumors von Lacombe, C., Perrier, M., Hentic, O., Brixi, H., Rebours, V., Cadiot, G., Ruszniewski, P., de Mestier, L.

Volltext

Everolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study von Walter, T., Lepage, C., Coriat, R., Barbier, E., Cadiot, G., Caroli Bosc, F.X., Aparicio, T., Bouhier Leporrier, K., Hentic Dhome, O., Dupont-Gossart, A.-C., Duluc, M., Lepere, C., Lecomte, T., Smith, D., Petorin, C., Iwanicki Caron, I., Ducreux, M.P., Lombard Bohas, C., de Baere, T.

Volltext

Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study von Maire, Frédérique, Lombard-Bohas, Catherine, O’Toole, Dermot, Vullierme, Marie-Pierre, Rebours, Vinciane, Couvelard, Anne, Pelletier, Anne Laure, Zappa, Magaly, Pilleul, Frank, Hentic, Olivia, Hammel, Pascal, Ruszniewski, Philippe

Volltext

Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial von Partelli, S, Massironi, S, Zerbi, A, Niccoli, P, Kwon, W, Landoni, L, Panzuto, F, Tomazic, A, Bongiovanni, A, Kaltsas, G, Sauvanet, A, Bertani, E, Mazzaferro, V, Caplin, M, Armstrong, T, Weickert, MO, Ramage, J, Segelov, E, Butturini, G, Staettner, S, Cives, M, Frilling, A, Moulton, CA, He, J, Boesch, F, Selberheer, A, Twito, O, Castaldi, A, De Angelis, CG, Gaujoux, S, Holzer, K, Wilson, CH, Almeamar, H, Vigia, E, Muffatti, F, Luca, M, Lania, A, Ewald, J, Kim, H, Salvia, R, Rinzivillo, M, Smid, A, Gardini, A, Tsoli, M, Hentic, O, Colombo, S, Citterio, D, Toumpanakis, C, Ramsey, E, Randeva, HS, Srirajaskanthan, R, Croagh, D, Regi, P, Gasteiger, S, Invernizzi, P, Ridolfi, C, Giovannini, M, Jang, JY, Bassi, C, Falconi, M

Volltext

213P Clinical characteristics and treatment outcomes of primary hepatic neuroendocrine neoplasms (PHNEN) von Apostolidis, L., de Mestier du Bourg, L., Kender, Z., Flegka, V., Winkler, E.C., Krug, S., Kratochwil, C., Hentic Dhome, O., Ruszniewski, P., Cros, J., Goeppert, B., Roessler, S.

Volltext

P-139 Efficacy of a Sequential Treatment Strategy with GEMOX Followed by FOLFIRI in Advanced Cholangiocarcinoma von Sebbagh, S., Roux, J., Dreyer, C., Neuzillet, C., de Gramont, A., Orbegoso, C., Hentic, O., Hammel, P., Raymond, E., André, T., Chibaudel, B., Faivre, S.

Volltext

Chemotherapy for Gastro-Enteropancreatic Endocrine Tumours von O’Toole, Dermot, Hentic, Olivia, Corcos, Olivier, Ruszniewski, Philippe

Volltext

LBA54 Alkylating agent-based vs oxaliplatin-based chemotherapy in neuroendocrine tumours according to the O6-methylguanine-DNA methyltransferase (MGMT) status: A randomized phase I... von Walter, T., Lecomte, T., Hadoux, J., Niccoli, P., Saban-Roche, L., Gaye, E., Guimbaud, R., Baconnier, M., Hautefeuille, V., Do Cao, C., Petorin, C., Hentic Dhome, O., Perrier, M., Aparicio, T., Scoazec, J-Y., Lombard Bohas, C., Bin, S., Hervieu, V., Barritault, M., Gerard, L.

Volltext

1163P - Response Evaluation Using Recist and Choi Criteria in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors (PNET) Treated with Sunitinib or Everolimus von Dreyer, C., Hentic, O., Zappa, M., Hammel, P., Bouattour, M., Mateescu, C., Faivre, S., Ruszniewski, P., Raymond, E.

Volltext